Facebook
X
LinkedIn
Forward| Biogen- Exhibitor | |
|---|---|
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. At the same time, we are working with leading academic institutions and MS treatment centers to advance better ways to diagnose, monitor and manage MS. We are also driving advances toward precision medicine by using new technologies to develop innovative programs and tools to better understand, measure and manage the treatment of MS. Together with our partners, we are working to enable doctors and patients to make more evidence-based, individualized treatment decisions with the goal of improving MS care. Our innovative research collaborations merge technologies like biomarkers and wearable sensors with real-world data from routine care to generate standardized, high-quality data that may help drive personalized treatment. We developed one of the world’s largest MS databases to investigate critical questions about this disease, including if there are potential predictors of MS progression, or if certain treatments used early enough may have potential long-term benefits for patients, such as delaying the need for walking aids and wheelchairs or slowing the deterioration of other critical functions. The work we are doing today in MS is designed to expand our focus well-beyond treatment and is vital to helping us better understand this disease. | |
